170 related articles for article (PubMed ID: 17617852)
1. NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism.
Hamby K; Trexler A; Pearson TC; Larsen CP; Rigby MR; Kean LS
Am J Transplant; 2007 Aug; 7(8):1884-96. PubMed ID: 17617852
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts.
Raziuddin A; Bennett M; Winkler-Pickett R; Ortaldo JR; Longo DL; Murphy WJ
Blood; 2000 Jun; 95(12):3840-4. PubMed ID: 10845918
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
[TBL] [Abstract][Full Text] [Related]
4. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation.
Wang JW; Howson JM; Ghansah T; Desponts C; Ninos JM; May SL; Nguyen KH; Toyama-Sorimachi N; Kerr WG
Science; 2002 Mar; 295(5562):2094-7. PubMed ID: 11896280
[TBL] [Abstract][Full Text] [Related]
5. Role of natural killer cell subsets in cardiac allograft rejection.
McNerney ME; Lee KM; Zhou P; Molinero L; Mashayekhi M; Guzior D; Sattar H; Kuppireddi S; Wang CR; Kumar V; Alegre ML
Am J Transplant; 2006 Mar; 6(3):505-13. PubMed ID: 16468959
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the NK cell alloreactivity to bone marrow cells by the combination of the host NK gene complex and MHC haplotypes.
Iizuka K; Scalzo AA; Xian H; Yokoyama WM
J Immunol; 2008 Mar; 180(5):3260-7. PubMed ID: 18292550
[TBL] [Abstract][Full Text] [Related]
7. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
Austin Taylor M; Bennett M; Kumar V; Schatzle JD
J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
[TBL] [Abstract][Full Text] [Related]
8. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants.
Liu J; Morris MA; Nguyen P; George TC; Koulich E; Lai WC; Schatzle JD; Kumar V; Bennett M
J Immunol; 2000 Feb; 164(4):1793-9. PubMed ID: 10657626
[TBL] [Abstract][Full Text] [Related]
9. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections.
Tay CH; Yu LY; Kumar V; Mason L; Ortaldo JR; Welsh RM
J Immunol; 1999 Jan; 162(2):718-26. PubMed ID: 9916691
[TBL] [Abstract][Full Text] [Related]
10. Tolerance and alloreactivity of the Ly49D subset of murine NK cells.
George TC; Ortaldo JR; Lemieux S; Kumar V; Bennett M
J Immunol; 1999 Aug; 163(4):1859-67. PubMed ID: 10438920
[TBL] [Abstract][Full Text] [Related]
11. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
Taylor MA; Ward B; Schatzle JD; Bennett M
Eur J Immunol; 2002 Mar; 32(3):793-9. PubMed ID: 11870623
[TBL] [Abstract][Full Text] [Related]
12. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Murphy WJ
Int Immunol; 1996 Dec; 8(12):1833-9. PubMed ID: 8982767
[TBL] [Abstract][Full Text] [Related]
13. Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48.
Yang TY; Sun Y; Langnas AN; Zhao Y
Clin Immunol; 2003 Feb; 106(2):148-54. PubMed ID: 12672405
[TBL] [Abstract][Full Text] [Related]
14. Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice.
McVicar DW; Winkler-Pickett R; Taylor LS; Makrigiannis A; Bennett M; Anderson SK; Ortaldo JR
J Immunol; 2002 Aug; 169(4):1721-8. PubMed ID: 12165492
[TBL] [Abstract][Full Text] [Related]
15. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection.
Held W; Cado D; Raulet DH
J Exp Med; 1996 Nov; 184(5):2037-41. PubMed ID: 8920892
[TBL] [Abstract][Full Text] [Related]
16. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts.
Ogasawara K; Benjamin J; Takaki R; Phillips JH; Lanier LL
Nat Immunol; 2005 Sep; 6(9):938-45. PubMed ID: 16086018
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
Hayakawa Y; Kelly JM; Westwood JA; Darcy PK; Diefenbach A; Raulet D; Smyth MJ
J Immunol; 2002 Nov; 169(10):5377-81. PubMed ID: 12421908
[TBL] [Abstract][Full Text] [Related]
18. The requirement for NKG2D in NK cell-mediated rejection of parental bone marrow grafts is determined by MHC class I expressed by the graft recipient.
Beilke JN; Benjamin J; Lanier LL
Blood; 2010 Dec; 116(24):5208-16. PubMed ID: 20736452
[TBL] [Abstract][Full Text] [Related]
19. Altered donor and recipient Ly49+ NK cell subsets in allogeneic H-2d --> H-2b and H-2b --> H-2d bone marrow chimeras.
Korten S; Wilk E; Gessner JE; Meyer D; Schmidt RE
J Immunol; 1999 Dec; 163(11):5896-905. PubMed ID: 10570275
[TBL] [Abstract][Full Text] [Related]
20. Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing.
Komatsu M; Mammolenti M; Jones M; Jurecic R; Sayers TJ; Levy RB
Blood; 2003 May; 101(10):3991-9. PubMed ID: 12521999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
